Thyroid Cancer pp 179-198 | Cite as

False-Positive Radioiodine Scans in Thyroid Cancer

  • Brahm Shapiro
  • Vittoria Rufini
  • Ayman Jarwan
  • Onelio Geatti
  • Kimberlee J. Kearfott
  • Lorraine M. Fig
  • Ian D. Kirkwood
  • John E. Freitas
  • Milton D. Gross

Abstract

The whole-body radioiodine scan remains an important component in the postoperative treatment of patients with well-differentiated thyroid cancer. Because normal thyroid tissue remnants and residual or metastatic foci of well-differentiated thyroid cancer have the unique ability to concentrate, organify, and store radioiodine, the wholebody scan provides a depiction of those tissues that can be ablated with therapeutic doses of radioiodine. Over time, it has become obvious that the whole-body scan may also reveal foci of radioiodine accumulation from a wide variety of other causes. This chapter provides an update of an article in the Seminars of Nuclear Medicine* in 2000 that detailed the pathophysiological classification of artifacts, anatomic and physiological variants, and nonthyroidal diseases that may give rise to false-positive whole body scans in postoperative patients with thyroid cancer.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bakheet SM, Hammami MM. False positive radioiodine whole-body scan in thyroid cancer patients due to unrelated pathology. Clin Nucl Med 1994; 19:325–329.PubMedGoogle Scholar
  2. 2.
    Berson SA, Yalow RS. Quantitative aspects of iodine metabolism: The exchangeable organic iodine pool and the rates of thyroid secretion, peripheral degradation and fecal excretion of endogenously synthesized organically bound iodine. J Clin Invest 1954; 33:1533–1552.PubMedGoogle Scholar
  3. 3.
    Cavalieri RR. Nuclear imaging in the management of thyroid carcinoma. Thyroid 1996; 6:485–492.PubMedGoogle Scholar
  4. 4.
    Datz FL. Gamuts in Nuclear Medicine, 3rd ed. St. Louis, MO: Mosby-Yearbook, 1995:14–15, 27–34.Google Scholar
  5. 5.
    Echenique R, Kasi L, Haynie TP, Glenn HJ, et al. Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: Concise communication. J Nucl Med 1982; 23:235–240.PubMedGoogle Scholar
  6. 6.
    Fogelman I, Maisey MN. The thyroid scan in the management of thyroid disease. In Freeman LM, Weissmann HS, editors. Nuclear Medicine Annual. New York: Raven Press, 1989:1.Google Scholar
  7. 7.
    Freitas JE, Gross MD, Ripley S, Shapiro B. Radionuclide diagnosis and therapy of thyroid cancer: Current status report. Semin Nucl Med 1985; 15:106–131.PubMedGoogle Scholar
  8. 8.
    Johnson PM. Thyroid and whole-body scanning. In Werner SC, Ingbar SH, editors. The Thyroid, A Fundamental and Clinical Text, 4th ed. Hagerston, PA: Harper & Row, 1978:247–297.Google Scholar
  9. 9.
    Maxon RH, Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990; 19:685–718.PubMedGoogle Scholar
  10. 10.
    Ramanna L, Waxman AD, Brachman MB, Sensel N, et al. Correlation of thyroglobulin measurements and radioiodine scans in the follow-up of patients with differentiated thyroid cancer. Cancer 1985; 55:1525–1529.PubMedGoogle Scholar
  11. 11.
    Riggs DS. Quantitative aspects of iodine metabolism in man. Pharmacol Rev 1952; 4:283–293.Google Scholar
  12. 12.
    Sutter CW, Masilungan BG, Stadalnik RC. False-positive results of I-131 whole-body scans in patients with thyroid cancer. Semin Nucl Med 1995; 25:279–282.PubMedGoogle Scholar
  13. 13.
    Carlisle MR, Lu C, McDougall IR. The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings. Nucl Med Commun 2003; 24:715–735.PubMedGoogle Scholar
  14. 14.
    Mitchell G, Pratt BE, Vini L, McCready VR, et al. False positive 131I whole body scans in thyroid cancer. Br J Radiol 2000; 73:627–635.PubMedGoogle Scholar
  15. 15.
    Zalis ED, Ellison RB, Captain MC. A diagnostic pitfall with radioiodine scanning. Am J Roentgenol 1965; 94:837–838.Google Scholar
  16. 16.
    Wu S, Brown T, Milne N, Egbert R, et al. Iodine-131 total body scan: Extra-thyroidal uptake of radioiodine. Semin Nucl Med 1986; 16:82–84.PubMedGoogle Scholar
  17. 17.
    Wolff J. Iodide concentrating mechanisms. In Tall JE, Kopin IJ, Berson SA, editors. The Thyroid and Biogenic Amines: Methods in Investigative and Diagnostic Endocrinology, vol 1. Amsterdam: North-Holland Publishing Co, 1972:115–203.Google Scholar
  18. 18.
    Spitzweg C, Joba W, Eisenmenger W, Heufelder AE. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 1998; 83:1746–1751.PubMedGoogle Scholar
  19. 19.
    Wayne EJ, Koutras DA, Alexander WD, editors. In Clinical Aspects of Iodine Metabolism. Philadelphia, PA: Davis Company 1964; 1–303.Google Scholar
  20. 20.
    Coover LR. False positive result of a total body scan caused by benign thyroidal tissue after 131I ablation. Clin Nucl Med 1999; 24:182–183.PubMedGoogle Scholar
  21. 21.
    Greenler DP, Klein HA. The scope of false-positive iodine-131 images for thyroid carcinoma. Clin Nucl Med 1989; 14:111–117.PubMedGoogle Scholar
  22. 22.
    Geatti O, Shapiro B, Orsolon PG, Mirolo R, et al. An unusual false positive scan in a patient with pericardial effusion. Clin Nucl Med 1994; 19:678–682.PubMedGoogle Scholar
  23. 23.
    Bakheet S, Powe J, Hammami M. Radioiodine uptake in the chest. J Nucl Med 1997; 38:984–986.PubMedGoogle Scholar
  24. 24.
    Bakheet S, Hammami M, Powe J. False-positive radioiodine uptake in the abdomen and the pelvis: Radioiodine retention in the kidneys and review of the literature. Clin Nucl Med 1996; 21:932–937.PubMedGoogle Scholar
  25. 25.
    Turlington B. Embryology and anatomy of the thyroid and parathyroid glands. In Eisenberg B, editor. Imaging of the Thyroid and Parathyroid Glands. New York: Churchill Livingstone Inc., 1991:1–8.Google Scholar
  26. 26.
    Larochelle D, Arcand P, Belzile M, Gagnon NB. Ectopic thyroid tissue: A review of the literature. J Otolaryngol 1979; 8:523–530.PubMedGoogle Scholar
  27. 27.
    Sloan LW, Feind CR. Clinical aspects of anomalous development. In Werner SC, Ingbar SH, editors. The Thyroid. New York: Harper & Row, 1971:317–333.Google Scholar
  28. 28.
    Weider DJ, Parker W. Lingual thyroid. Ann Otol Rhinol Laryngol 1977; 86:841–848.PubMedGoogle Scholar
  29. 29.
    Strain J, Oates E, Nejad A. Unusual appearance of lingual thyroid in congenital hypothyroidism. Clin Nucl Med 1998; 23:460.PubMedGoogle Scholar
  30. 30.
    Coover L. False-positive result of a total-body scan caused by benign thyroidal tissue after I-131 ablation. Clin Nucl Med 1999; 24:182–183.PubMedGoogle Scholar
  31. 31.
    Lin DS. Thyroid imaging-mediastinal uptake in thyroid imaging. Semin Nucl Med 1983; 13:395–396.PubMedGoogle Scholar
  32. 32.
    Leung AKC, Wong AL, Robson WLM. Ectopic thyroid gland simulating a thyroglossal duct cyst: A case report. Can J Surg 1995; 38:87–89.PubMedGoogle Scholar
  33. 33.
    Sironi M, Assi A, Andruccioli M, Spreafico G. Submandibular ectopic thyroid gland. Clin Nucl Med 1996; 21:585.PubMedGoogle Scholar
  34. 34.
    Touliopoulos P, Oates E. Autonomously functioning thyroid rests following total thyroidectomy for Graves’ disease. Clin Nucl Med 1993; 18:914.PubMedGoogle Scholar
  35. 35.
    Dowling EA, Johnson IM, Collier FCD. Intratracheal goiter: A clinico-pathologic review. Ann Surg 1962; 156:258–267.PubMedGoogle Scholar
  36. 36.
    Dundas P. Intrathoracic aberrant goiter. Acta Chir Scand 1964; 128:729–736.PubMedGoogle Scholar
  37. 37.
    Fogelfeld L, Rubinstein U, Bar-On J, Feigl D. Severe thyrotoxicosis caused by an ectopic intrathoracic goiter. Clin Nucl Med 1986; 11:20–22.PubMedGoogle Scholar
  38. 38.
    Salvatore M, Gallo A. Accessory thyroid in the anterior mediastinum: Case report. J Nucl Med 1975; 16:1135–1136.PubMedGoogle Scholar
  39. 39.
    Salvatore M, Rufini V, Corsellow SM, Saletnich I, et al. Thyrotoxicosis due to ectopic retrotracheal adenoma treated with radioiodine. J Nucl Biol Med 1993; 37:69–72.Google Scholar
  40. 40.
    Thakore K, Vansant J. Hyperthyroidism die to toxic, intrathoracic thyroid tissue with absent cervical thyroid gland. Clin Nucl Med 1993; 18:535–536.PubMedGoogle Scholar
  41. 41.
    Rieser GD, Ober KP, Cowan RJ, Cordell AR. Radioiodine imaging of struma cordis. Clin Nucl Med 1988; 13:421–422.PubMedGoogle Scholar
  42. 42.
    Aldasouqi S, Edmondson J, Prince M. Carcinoma of thyro-glossal duct remnants: Report of three cases and a review of the literature. The Endocrinologist 1996; 6:238–244.Google Scholar
  43. 43.
    Gaby M. The role of thyroid dysgenesis and maldescent in the etiology of sporadic cretinism. J Pediatr 1962; 60:830–835.Google Scholar
  44. 44.
    Gorbman A, Dickhoff WW, Vigna SR. The thyroid gland. In Gorbman A, editor. Comparative Endocrinology. New York: John Wiley and Sons, 1983:185–202.Google Scholar
  45. 45.
    Myers EN, Pantangco IP. Intratracheal thyroid. Laryngoscope 1975; 85:1833–1840.PubMedGoogle Scholar
  46. 46.
    Postlethwait RN, Detmer DE. Ectopic thyroid nodule in the esophagus. Ann Thorac Surg 1975; 19:98–100.PubMedGoogle Scholar
  47. 47.
    Brown WW, Shetty KR, Rosenfeld PS. Hyperthyroidism due to struma ovarii: Demonstration by radioiodine scan. Acta Endocrinol 1973; 73:266–272.PubMedGoogle Scholar
  48. 48.
    Falsetti L, Schivardi MR, Maira G, Favret M, et al. Riscontro di struma ovarii in una paziente in trattamento per cacinoma tiroideo. Ann Ost Gin Med Perin 1985; 106:290–293.Google Scholar
  49. 49.
    March DE, Desai AG, Park CH, Hendricks PJ. Struma ovarii: Hyperthyroidism in a postmenopausal woman. J Nucl Med 1988; 29:263–265.PubMedGoogle Scholar
  50. 50.
    Salvatore M, Rufini V, Daudone MS. Occasional detection of “struma ovarii” in a patient with thyroid cancer. Radiol Med (Torino) 1991; 81:744–767.Google Scholar
  51. 51.
    Thomas RD, Batty VB. Metastatic malignant struma ovarii: Two case reports. Clin Nucl Med 1992; 17:577–578.PubMedGoogle Scholar
  52. 52.
    Yeh E-L, Meade RC, Reutz PP. Radionuclide study of struma ovarii. J Nucl Med 1973; 14:118–121.PubMedGoogle Scholar
  53. 53.
    Zwas ST, Heyman Z, Lieberman LM. 131-I ovarian uptake in a wholebody scan for thyroid carcinoma. Semin Nucl Med 1989; 19:340–342.PubMedGoogle Scholar
  54. 54.
    Ziessman HA, Bahar H, Fahey FH, Dubiansky V. Hepatic visualization on iodine-131 whole-body thyroid cancer scans. J Nucl Med 1987; 28:1408–1411.PubMedGoogle Scholar
  55. 55.
    Joja I, Asakawa T, Mitsumori A, Nakagawa T, et al. I-123 uptake in non-functional struma ovarii. Clin Nucl Med 1998; 23:10–12.PubMedGoogle Scholar
  56. 56.
    Konez O, Hanelin LG, Jenison EL, Goyal M, et al. Functioning liver metastases on a whole-body scan: a case of malignant struma ovarii. Clin Nucl Med 2000; 25:465–466.PubMedGoogle Scholar
  57. 57.
    Moses DC, Thompson NW, Nishiyama RH, Sisson JC. Ectopic thyroid tissue in the neck, benign or malignant? Cancer 1976; 38:361–365.PubMedGoogle Scholar
  58. 58.
    Ryo UY, Stachura ME, Schneider AB, Nichols R, et al. Significance of extrathyroidal uptake of Tc-99m and I-123 in the thyroid scan: Concise communication. J Nucl Med 1981; 22:1039–1042.PubMedGoogle Scholar
  59. 59.
    Sud AM, Gross MD. Radioiodine uptake following thyroidectomy for thyroid cancer: Recurrence or ectopic tissue? Clin Nucl Med 1991; 16:894–897.PubMedGoogle Scholar
  60. 60.
    Todino V, Pacella CM, Crescenzi A. Ectopic thyroid tissue in the liver: Case report. Eur J Nucl Med 1996; 23(Abstr):1055.Google Scholar
  61. 61.
    Bakheet S, Powe J, Hammami MM, Amin TM, et al. Isolated porta hepatis metastasis of papillary thyroid cancer. J Nucl Med 1996; 37:993–994.PubMedGoogle Scholar
  62. 62.
    Feuerstein IM, Harbert JC. Hypertrophied thyroid tissue in a thyroglossal duct remnant. Clin Nucl Med 1986; 11:135.PubMedGoogle Scholar
  63. 63.
    Freinkel N, Ingbar SH. Concentration gradients for inorganic iiodide I-131 and chloride in mixed human saliva. J Clin Invest 1953; 32:1077–1084.PubMedGoogle Scholar
  64. 64.
    Ahlgren L, Ivarsson S, Johansson L, Mattsson S, et al. Excretion of radionuclides in human breast milk after the administration of radiopharmaceuticals. J Nucl Med 1985; 26:1085–1090.PubMedGoogle Scholar
  65. 65.
    Bakheet S, Hammami MM. False positive thyroid cancer metastasis on whole body radioiodine scanning due to retained radioactivity in the oesophagus. Eur J Nucl Med 1993; 20:415–419.PubMedGoogle Scholar
  66. 66.
    Boxen I, Zhang M. Nasal secretion of iodine-131. Clin Nucl Med 1990; 15:610–611.PubMedGoogle Scholar
  67. 67.
    Coakley AJ, Mountford PJ. Nuclear medicine and the nursing mother. Br Med J 1985; 291:159–160.Google Scholar
  68. 68.
    Clode WH, Sobral JMV, Lima-Basto E. Elective uptake of radioiodine by cancer of the stomach. Surgery 1961; 50:725–727.PubMedGoogle Scholar
  69. 69.
    Duong RB, Fernandez-Ulloa M, Planitz MK, Maxon, HR. 123I breast uptake in a young primipara with postpartum transient thyrotoxicosis. Clin Nucl Med 1983; 8:35.PubMedGoogle Scholar
  70. 70.
    Ganatra RD, Atmaram SH, Sharma SM. An unusual site of radioiodine concentration in a patient with thyroid cancer (letter). J Nucl Med 1972; 13:777.PubMedGoogle Scholar
  71. 71.
    Hedrick WR, DiSimone RN, Keen RL. Radiation dosimetry from breast milk excretion of radioiodine and pertechnetate. J Nucl Med 1986; 27:1569–1571.PubMedGoogle Scholar
  72. 72.
    Honour AJ, Myant NB, Rowlands EN. Secretion of redioiodine in digestive juices and milk in man. Clin Sci (Colch) 1952; 11:447–462.Google Scholar
  73. 73.
    Lopez OL, Maisano ER. Vascular retention of Tc-99m pertechnetate simulating ectopic or metastatic thyroid tissue. Clin Nucl Med 1983; 8:503–504.PubMedGoogle Scholar
  74. 74.
    Malpani BL, Samuel AM, Ray S. Defferential kinetics of parotid and submandibular gland function as demonstrated by scintigraphi means and its possible implications. Nucl Med Commun 1995; 16:706–709.PubMedGoogle Scholar
  75. 75.
    Mountford PJ, Coakley AJ. A review of the secretion of radioactivity in human breast milk: Data, quantitative analysis and recommendations. Nucl Med Commun 1989; 10:15–27.PubMedGoogle Scholar
  76. 76.
    Neutze JA, Norby EH, Van Nostrand D. Nasal radioiodine uptake: A prospective study of frequency, degree, and pattern. J Nucl Med 1987:28:686.Google Scholar
  77. 77.
    Norby EH, Neutze J, Van Nostrand D, Burman KD, et al. Nasal radioiodine activity: A prospective study of frequency, intensity and pattern. J Nucl Med 1990; 31:52–54.PubMedGoogle Scholar
  78. 78.
    Park HM, Tarver RD, Schauwecker DS, Burt R. Spurious thyroid cancer metastasis: Saliva contamination artifact in high dose iodine-131 metastases survey. J Nucl Med 1986; 27:634–636.PubMedGoogle Scholar
  79. 79.
    Riccabona G. Differentiated thyroid carcinoma. In Murray IPC, Ell PJ, editors. Nuclear Medicine in Clinical Diagnosis and Treatment. Churchill Livingstone, 1998:941–957.Google Scholar
  80. 80.
    Romney, B, Nicholoff EF, Esser PD. Excretion of radioiodine in breast milk. J Nucl Med 1989; 30:124–126.PubMedGoogle Scholar
  81. 81.
    Romney BM, Nicholoff EL. Diagnostic nuclear medicine and the nursing mother. App Radiol 1987; 16:51–56.Google Scholar
  82. 82.
    Romney BM, Nickoloff EL, Esser PD. Radionuclide administration to nursing mothers: Mathematically derived guidelines. Radiology 1986; 160:549–554.PubMedGoogle Scholar
  83. 83.
    Schuster DM, Alazraki N. Esophageal scarring causing false-positve uptake on I-131 whole-body imaging. Clin Nucl Med 1998; 23:334.PubMedGoogle Scholar
  84. 84.
    Hammami MM, Bakheet S. Radioiodine breast uptake in non-breast feeding women. Clinical and scintigraphic characteristics. J NuclMed 1996; 37:26–31.Google Scholar
  85. 85.
    Park HM, Wellman H. Hot nose after I-131 sodium iodide thyroablation therapy. Clin Nucl Med 1992; 17:130–131.PubMedGoogle Scholar
  86. 86.
    Allen T, Wiest P, Vela S, Hartshorne M, Crooks LA. I-131 uptake in the breast for thyroid cancer surveillance with biopsy-proven benign tissue. Clin Nucl Med 1998; 23:585–587.PubMedGoogle Scholar
  87. 87.
    Baemler GR, Joo KG. Radioactive iodine uptake by breasts (letter). J Nucl Med 1986; 27:149–151.Google Scholar
  88. 88.
    Watanabe N, Matsumoto M, Ohtake H, Hirano T, et al. Bilateral breast uptake of T1-201 chloride in a nursing woman. Clin Nucl Med 1996; 21:818–819.PubMedGoogle Scholar
  89. 89.
    McDougall IR. Whole body scintigraphy with radioiodine-131: A comprehensive list of false-positives with some examples. Clin Nucl Med 1995; 20:869–875.PubMedGoogle Scholar
  90. 90.
    Robinson PS, Barker P, Campbell A, Henson P, et al. Iodine-131 in breast milk following therapy for thyroid carcinoma. J Nucl Med 1994; 35:1797–1801.PubMedGoogle Scholar
  91. 91.
    Bakheet S, Hammami M, Hemidan A, Powe JE, et al. Radioiodine secretion in tears. J Nucl Med 1998; 39:1452–1454.PubMedGoogle Scholar
  92. 92.
    Bakheet SM, Hammami MM. Patterns of radioiodine uptake by the lactating breast. Eur J Nucl Med 1994; 21:604–608.PubMedGoogle Scholar
  93. 93.
    Howarth DV, Forstrom LA, O’Connor MK, Thomas PA, et al. Patientrelated and pitfalls artifacts in nuclear medicine imaging. Semin Nucl Med 1996; 26:295–307.PubMedGoogle Scholar
  94. 94.
    Achong DM, Oates E, Lee SL, Doherty FJ. Gallbladder visualization during post-therapy iodine-131 imaging of thyroid carcinoma. J Nucl Med 1991; 32:2275–2277.PubMedGoogle Scholar
  95. 95.
    Nishizawa K, Ohara K, Ohshima M, Maekoshi H, et al. Monitoring of iodine excretions and used materials of patients treated with 131I. Health Phys 1980; 38:467–481.PubMedGoogle Scholar
  96. 96.
    Daumerie C, Vynckier S, Caussin J, Jadoul M, et al. Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis. Thyroid 1996; 6:301–304.PubMedGoogle Scholar
  97. 97.
    Howard N, Glasser M. Iodine-131 ablation therapy for a patient on maintenance haemodialysis. Br J Radiol 1981; 54:259–261.PubMedGoogle Scholar
  98. 98.
    Mello AM, Isaacs R, Petersen J, Kronenberger S, et al. Management of thyroid papillary carcinoma with radioiodine in a patient with end-stage renal disease on hemodialysis. Clin Nucl Med 1994; 19:776–781.PubMedGoogle Scholar
  99. 99.
    Morrish DW, Filipow JL, McEwan AJ, Schmidt R, et al. 131I treatment of thyroid papillary carcinoma in a patient with renal failure. Cancer 1990; 66:2509–2513.PubMedGoogle Scholar
  100. 100.
    Nibhanupudy JR, Hamilton W, Sridhar R, Talley GB, et al. Iodine-131 treatment of hyperthyroidism in a patient on dialysis for chronic renal failure. Am J Nephrol 1993; 13:214–217.PubMedGoogle Scholar
  101. 101.
    Rosenbaum RC, Johnston GS, Valente WA. Frequency of hepatic visualization during 131I imaging for metastatic thyroid carcinoma. Clin Nucl Med 1988; 13:657–660.PubMedGoogle Scholar
  102. 102.
    Schober B, Cohen P, Lyster D, Charron M, et al. Diffuse liver uptake of 131I (letter). J Nucl Med 1990; 31:1575–1576.PubMedGoogle Scholar
  103. 103.
    Nodine JH, Maldia G. Pseudostruma ovarii. Obstet Gynecol 1961; 17:460–463.PubMedGoogle Scholar
  104. 104.
    You DL, Tzen KY, Chen JF, Kao PF, et al. False-positive whole-body iodine-131 scan due to intrahepatic duct dilatation. J Nucl Med 1997; 38:1977–1979.PubMedGoogle Scholar
  105. 105.
    Chung JK, Lee YJ, Jeong JM, Lee DS, et al. Clinical significance of hepatic visualization on I-131 whole-body scan in patients with thyroid carcinoma. J Nucl Med 1997; 38:1191–1195.PubMedGoogle Scholar
  106. 106.
    Muherji S, Ziessman HA, Earll JM, Keyes JW. False-positive iodine-131 whole-body scan due to pectus excavatum. Clin Nucl Med 1988; 13:207–208.PubMedGoogle Scholar
  107. 107.
    Giuffrida D, Garofalo MR, Cacciaguerra G, Freni V, et al. False positive I-131 tatal body scan due to an ectasia of the common carotids. J Endocrinol Invest 1993; 16:207–211.PubMedGoogle Scholar
  108. 108.
    Abdel-Dayem HM, Halker K, El Sayed M. The radioactive wig in iodine-131 whole-body imaging. Clin Nucl Med 1984; 9:454–455.PubMedGoogle Scholar
  109. 109.
    Varoglu E, Yildirim M, Bayrakdar R, Kantalri AM, et al. Radioiodine pooling in dilated greater saphenous vein mimicking contamination. Clin Nucl Med 2003; 28:866–868.PubMedGoogle Scholar
  110. 110.
    Bakheet SM, Hammami MM. Spurious thyroid cancer bone metastases on radioiodine scan due to external contamination. Eur J Radiol 1993; 16:239–242.PubMedGoogle Scholar
  111. 111.
    Bakheet S, Jammami MM. Spurious lung metastases on radioiodine thyroid and whole body imaging. Clin Nucl Med 1993; 18:307–312.PubMedGoogle Scholar
  112. 112.
    Brodkey JS, Gibbs GE. Sweat iodide excretion in patients with cystic fibrosis of the pancreas. J Appl Physiol 1960; 15:501–502.PubMedGoogle Scholar
  113. 113.
    Camponovo EJ, Goyer PF, Silverman ED, Kistler AM, et al. Axillary iodine-131 accumulation due to perspiration. Clin Nucl Med 1989; 14:762–763.PubMedGoogle Scholar
  114. 114.
    Chandramouly BS, Scagnelli T, Burgess CK. Artifact on iodine-131 whole body scan due to contaminated handkerchief. Clin Nucl Med 1989; 14:762–763.Google Scholar
  115. 115.
    Dick C, Mudun A, Alazraki NP. False-positive images mimicking thyroid cancer metastasis: The nose ring sign. Clin Nucl Med 1995; 20:876–877.PubMedGoogle Scholar
  116. 116.
    Gritters LS, Wissing J, Gross MD, Shapiro B. Extensive salivary contamination due to concurrent use of chewing tobacco during I-131 radioablative therapy. Clin Nucl Med 1993; 18:115–117.PubMedGoogle Scholar
  117. 117.
    Ibis E, Wilson CR, Collier BD, Akansel G, et al. Iodine-131 contamination from thyroid cancer patients. J Nucl Med 1992; 33:2110–2115.PubMedGoogle Scholar
  118. 118.
    Pochis WT, Krasnow AZ, Isitman AT, Cerletty JM, et al. The radioactive handkerchief sign: A contamination artifact in I-131 imaging for metastatic thyroid carcinoma. Clin Nucl Med 1990; 15:491–494.PubMedGoogle Scholar
  119. 119.
    Carey JE, Kumpuris TM, Wrobel MC. Release of patients containing therapeutic dosages of iodine-131 from hospitals. J Nucl Med Technol 1995; 23:144–149.Google Scholar
  120. 120.
    Ryo UY, Alavi A, Collier BD, editors. The thyroid. In Atlas of Nuclear Medicine Artifacts and Variants. Chicago: Yearbook Medical Publishers, 1995:23–33.Google Scholar
  121. 121.
    Silva F, Negron JA. Unusual contamination after a therapeutic dose of iodine-131. J Nucl Med 1996; 37:70,75.Google Scholar
  122. 122.
    Ain KB, Shih WJ. False-positive I-131 uptake at a tracheostomy site: discernment with T1-201 imaging. Clin Nucl Med 1994; 19:619–621.PubMedGoogle Scholar
  123. 123.
    Kirk GA, Schulz EE. Post-laryngectomy localization of I-131 at tracheostomy site on a total body scan. Clin Nucl Med 1984; 9:409–411.PubMedGoogle Scholar
  124. 124.
    Joyce WT, Cowan RJ. A potential false-positive post-therapy radioiodine scan secondary to I-131 excretion in perspiration. Clin Nucl Med, 1995; 20:368–369.PubMedGoogle Scholar
  125. 125.
    Lawes SC. 123I excretion in breast milk-additional data. Nucl Med Commun 1992; 13:570–572.PubMedGoogle Scholar
  126. 126.
    Weaver JC, Kamm ML, Dobson RL. Excretion of radioiodine in human milk. JAMA 1960; 173:872–875.PubMedGoogle Scholar
  127. 127.
    Spencer RP, Spitznagle LA, Karimeddini MK, Hosain F. Breast milk content of 131I in a hypothyroid patient. Nucl Med Biol 1986; 13:585.Google Scholar
  128. 128.
    Wiseman J. Bony metastasis from thyroid carcinoma or contamination? Clin Nucl Med 1984; 9:363.PubMedGoogle Scholar
  129. 129.
    Schechter D, Krausz Y, Moshe S, Rubinstein R, et al. Radioiodine hot hand sign. Clin Nucl Med 1998; 23:378–379.PubMedGoogle Scholar
  130. 130.
    Barzel US, Chun KJ. Artifact of I-131 whole-body scan with thoracic vertebral uptake in a patient with papillary thyroid carcinoma. Clin Nucl Med 1997; 22:855.PubMedGoogle Scholar
  131. 131.
    Caplan RH, Gundersen GA, Abellera M, Kisken WA. Uptake of iodine-131 by a Meckel’s diverticulum mimicking metastatic thyroid cancer. Clin Nucl Med 1987; 12:760–762.PubMedGoogle Scholar
  132. 132.
    Ho Y, Hicks R. Hiatus hernia: A potential cause of false-positive iodine-131 scan in thyroid carcinoma. Clin Nucl Med 1998; 23:621–622.PubMedGoogle Scholar
  133. 133.
    Kamoi I, Nishitani H, Oshiumi Y, Ichiya Y, et al. Intrathoracic gastric cyst demonstrated by Tc-99m pertechnetate scintigraphy. AJR Am J Roentgenol 1980; 134:1080–1081.PubMedGoogle Scholar
  134. 134.
    McNamara M, Tsang H. Hiatal hernia with reflux resulting in false positive I-131 scan. Clin Nucl Med 1998; 23:178–179.PubMedGoogle Scholar
  135. 135.
    Misaki T, Iida Y, Kasayi K. First impressions: Unusual extrathyroidal uptake. J Nucl Med 1998; 39:1650.Google Scholar
  136. 136.
    Schneider JA, Divgi CR, Scott AM, Macapinlac HA, et al. Hiatal hernia on whole-body radioiodine survey mimicking metastic thyroid cancer. Clin Nucl Med 1993; 18:751–753.PubMedGoogle Scholar
  137. 137.
    Unal S, Oguz H, Alagol F, Cantez S. Misinterpretation of I-131 scintigraphy because of diaphragmatic hernia. Clin Nucl Med 1996; 21:151–152.PubMedGoogle Scholar
  138. 138.
    White JE, Flickinger FW, Morgan ME. 131I accumulation in gastric pull-up simulating pulmonary metastases on total-body scan for thyroid cancer. Clin Nuc Med 1990; 15:809–810.Google Scholar
  139. 139.
    Willis LL, Cowan RJ. Mediastinal uptake of I-131 in a hiatal hernia mimicking recurrence of papillary thyroid carcinoma. Clin Nucl Med 1993; 18:961–963.PubMedGoogle Scholar
  140. 140.
    Bekis R, Durak H. Intrathoracic stomach causing a pitfall on thyroid imaging. Clin Nucl Med 1998; 23:848–849.PubMedGoogle Scholar
  141. 141.
    Ceccarelli C, Pancini F, Lippi F, Pinchera A. An unusual case of a false-positive iodine-131 whole-body scan in a patient with papillary thyroid cancer. Clin Nucl Med 1987; 3:192–193.Google Scholar
  142. 142.
    Berquist TH, Nolan NG, Stephens DM. Radioisotope scintigraphy in diagnosis of Barrett’s esophagus. AJR Am J Roentgenol 1971; 123:401–411.Google Scholar
  143. 143.
    Boulahdour H, Meignan M, Melliere D, Braga F, et al. False-positive I-131 scan induced by Zenker’s diverticulum. Clin Nucl Med 1992; 17:243–244.PubMedGoogle Scholar
  144. 144.
    Dhawan VM, Kaess KR, Spencer RP. False positive thyroid scan due to zenker’s diverticulum. J Nucl Med 1978; 19:1231–1232.Google Scholar
  145. 145.
    Kistler AM, Yudt WM, Bakalar RS, Turton DB, et al. Retained esophageal activity on iodine-131 survey in patient with benign esophageal stricture. Clin Nucl Med 1993; 18:908–909.PubMedGoogle Scholar
  146. 146.
    Ozdemir A, Gungor F, Ozugur S, Cubuk M, et al. Abnormal iodine-131 uptake in the mediastinum caused by achalasia. Clin Nucl Med 1998; 23:706–707.PubMedGoogle Scholar
  147. 147.
    Grossman M. Gastroesophageal reflux: A potential source of confusion in technetium thyroid scanning: Case report. J Nucl Med 1977; 18:548–549.PubMedGoogle Scholar
  148. 148.
    Nair N, Basu S, Pakhale H. Unusual uptake of radioiodine in the chest in a patient with thyroid carcinoma. Br J Radiol 2004; 77:63–67.PubMedGoogle Scholar
  149. 149.
    Robertson JS, Verhasselt M, Wahner HW. Use of 123-I for thyroid uptake measurements and depression of 131-I thyroid uptake by incomplete dissolution of capsule filler. J Nucl Med 1974; 15:770–774.PubMedGoogle Scholar
  150. 150.
    Kipper MS, Krohn LD. Increased submandibular gland uptake on thyroid scintigraphy due to Wharton’s duct stone. Clin Nucl Med 1996; 21:881–882.PubMedGoogle Scholar
  151. 151.
    Kolla IS, Alazraki NP, Watts NB. Sialoadenitis mimicking metastatic thyroid carcinoma. Clin Nucl Med 1989; 14:564–566.PubMedGoogle Scholar
  152. 152.
    Tyson JW, Wilkinson RH, Witherspoon LR, Goodrich JK. Falsepositive I-131 total body scans. J Nucl Med 1974; 15:1052–1053.PubMedGoogle Scholar
  153. 153.
    Wolff H, Breda DJ, DaSilva N, Hartmann AA. False-positive I-131 deposition in a parotid gland duct ectasia. Clin Nucl Med 1998; 23:257–259.PubMedGoogle Scholar
  154. 154.
    Wendell TJ, Wilkinson RH, Witherspoon LR. False positive 131I totalbody scans. J Nucl Med 1974; 15:1052–1053Google Scholar
  155. 155.
    Carlisle M, Cortes A, McDougall IR. Uptake of I-131 in the biliary tract: A potential cause of a false-positive result of scintiscan. Clin Nucl Med 1998; 23:524–527.PubMedGoogle Scholar
  156. 156.
    Schall GL, Temple R. Importance of proper bowel cleansing before I-131 whole body scan or retention study. J Nucl Med 1972; 13:181–182.PubMedGoogle Scholar
  157. 157.
    Brachman MB, Rothman BJ, Ramanna L, Tanasescu DE, et al. Falsepositive iodine-131 body scan caused by a large renal cyst. Clin Nucl Med 1988; 13:416–418.PubMedGoogle Scholar
  158. 158.
    Bakheet MS, Powe J, Hammami MM. Unilateral radioiodine breast uptake. Clin Nucl Med 1998; 23:170–171.PubMedGoogle Scholar
  159. 159.
    Robinson PS, Surveyor I. Response to letter: Unilateral iodine-131 uptake in the lactating breast. J Nucl Med 1995; 36:1725.Google Scholar
  160. 160.
    Grunwald F, Palmedo H, Biersack HJ. Unilateral iodine-131 uptake in the lactating breast. J Nucl Med 1995; 36:1724–1725.PubMedGoogle Scholar
  161. 161.
    Serafini A, Sfakianakis G, Georgiou M, Morris J. Breast cyst simulating metastases of iodine-131 imaging in thyroid carcinoma. J Nucl Med 1998; 39:1910–1912.PubMedGoogle Scholar
  162. 162.
    Blue PW, Dydek GJ, Ghaed N. Radiation dosimetry from breast milk excretion of iodine-123. J Nucl Med 1987; 28:544–545.PubMedGoogle Scholar
  163. 163.
    Nurnberger CE, Lipscomb A. Transmission of radioiodine (I-131) to infants through human maternal milk. JAMA 1952; 150:1398–1400.Google Scholar
  164. 164.
    Rubow S, Klopper J. Excretion of radioiodine in human milk following a therapeutic dose of 131I. Eur J Nucl Med 1988; 14:632–633.PubMedGoogle Scholar
  165. 165.
    Maslack MM, Wilson CA. Iodine-131 accumulation in a pericardial effusion (letter). J Nucl Med 1987; 28:133.PubMedGoogle Scholar
  166. 166.
    Silva F, Garcia L, Flores C, Storer D, et al. Periicardial effusion: Unusual complication in thyroid cancer. Clin Nucl Med 1996; 21:218–220.PubMedGoogle Scholar
  167. 167.
    Haubold-Reuter BG, Landolt U, Schulthess GKV, et al. Bronchogenic carcinoma mimicking metastatic thyroid carcinoma. J Nucl Med 1993; 34:809–811.PubMedGoogle Scholar
  168. 168.
    Kim EE, Pjura G, Gobuty A, Verani R. 131-I uptake in a benign serous cystadenoma of the ovary. Eur J Nucl Med 1984; 9:433–435.PubMedGoogle Scholar
  169. 169.
    Francese C, Schlumberger M, Travagli JP, Vera P, et al. Iodine-131 uptake in a pleuropericardial cyst: Case report of a false-positive radioiodine total body scan result in a patient with a thyroid cancer. Eur J Nucl Med 1991; 18:779–780.PubMedGoogle Scholar
  170. 170.
    Bakheet SM, Hammami MM, Powe J. Radioiodine bronchogram in acute respiratory tract infection. Clin Nucl Med 1997; 22:308–309.PubMedGoogle Scholar
  171. 171.
    Duque JJ, Miguel MB, Ruiz E, Castillo L, et al. False-positive 131I whole-body scan in follicular thyroid carcinoma caused by frontal sinus mucocele. Clin Nucl Med 2000; 25:137–138.PubMedGoogle Scholar
  172. 172.
    Lungo M, Tenenbaum F, Chaumerliac P, Vons C, et al. Ovarian endometriosis cyst with iodine-131 uptake3: first case of positive uptake in the follow up for differentiated thyroid carcinoma. Ann Endocrinol (Paris) 2000; 61:147–150.Google Scholar
  173. 173.
    Bakheet SM, Hammami MM, Powe J. Radioiodine uptake in rheumatoid arthritis-associated lung disease mimicking thyroid cancer metastases. Clin Nucl Med 1998; 23:319–320.PubMedGoogle Scholar
  174. 174.
    Bakheet SM, Hammami MM, Powe J, Bazarbashi M, et al. Radioiodine in inactive tuberculosis. Eur J Nucl Med 1999; 26:659–662.PubMedGoogle Scholar
  175. 175.
    Regalbuto C, Buscema M, Arena S, Vigneri R, et al. False-positive findings on 131I whole-body scans because of posttraumatic superficial scabs. J Nucl Med 2002; 43:207–209.PubMedGoogle Scholar
  176. 176.
    Hoschl R, Choy DHL, Grandevia B. Iodine-131 uptake in inflammatory lung disease: A potential pitfall in treatment of thyroid carcinoma. J Nucl Med 1988; 29:701–706.PubMedGoogle Scholar
  177. 177.
    Herzog G, Kisling G, Bekerman C. Diagnostic significance of dental history in the clinical evaluation of patients with thyroid carcinoma: Periodontal surgery mimicking a metastasis on I-131 whole-body survey. Clin Nucl Med 1992; 17:589–590.PubMedGoogle Scholar
  178. 178.
    Wadhwa SS, Mansberg R. Benign oral disease as a cause of falsepositive iodine-131 scans. Clin Nucl Med 1998; 23:747–749.PubMedGoogle Scholar
  179. 179.
    Otsuka N, Fukunaga M, Morita K, Ono S, et al. 131I uptake in patient with thyroid cancer and rheumatoid arthritis during acupuncture treatment. Clin Nucl Med 1990; 15:29–31.PubMedGoogle Scholar
  180. 180.
    Matheja P, Lerch H, Schmid K, Kuwert T, et al. Frontal sinus mucocele mimicking a metastasis of papillary thyroid carcinoma. J Nucl Med 1997; 38:1022–1024.PubMedGoogle Scholar
  181. 181.
    Brucker-Davis F, Reynolds JC, Skarulis MC, Fraker DL, et al. Falsepositive iodine-131 whole-body scans due to cholecystitis and sebaceous cyst. J Nucl Med 1996; 37:1690–1693.PubMedGoogle Scholar
  182. 182.
    Bakheet SM, Hammami MM, Powe J, et al. Radioiodine in the head and neck. Endocr Pract 2000; 6:37–41.PubMedGoogle Scholar
  183. 183.
    Kinuya S, Yokoyama K, Michigishi T. I-131 accumulation in folliculitis of the scalp. Clin Nucl Med 1996; 21:807–808.PubMedGoogle Scholar
  184. 184.
    Froncova K. Uptake of radioiodine by myocardium following infarction. Cas Lek Cesk 1978; 103:64.Google Scholar
  185. 185.
    Turoglu HT, Naddaf S, Young I, Abel-Dayem H. Infected sebaceous cyst: A cause for false-positive total-body I-123 metastatic survey for thyroid cancer. Clin Nucl Med 1996; 23:887.Google Scholar
  186. 186.
    Naddaf S, Akisik MF, Omar WS, Young I, et al. I-123 uptake in the chest wall after needle biopsy of a pulmonary nodule. Clin Nucl Med 1997; 22:572573.Google Scholar
  187. 187.
    Langsteger W, Koltringer P, Meister E, Eber O. False-positive scans in papillary thyroid carcinoma (letter). J Nucl Med 1993; 34:2280.PubMedGoogle Scholar
  188. 188.
    Wu S, Kollin J, Coodley E, Lockyer T, et al. I-131 total body scan: Localization of disseminated gastric adenocarcinoma. Case report and survey of the literature. J Nucl Med 1984; 25:1204–1209.PubMedGoogle Scholar
  189. 189.
    Berding G, Forsting M, Georgi P. Unspezifische speichergung in J-131-Ganzkorperszintigramm bei de Nachsorgeeines metasterierienden papillaren. Schilddrusencarcinoms bedingt durch ein meningeom. Nuc Compact 1990; 21:163–164.Google Scholar
  190. 190.
    Priesman RA, Halpern SE, Shishido R, Waltz T, et al. Uptake of 131-I by a papillary meningioma. AJR Am J Roentgenol 1977; 128:349–350.Google Scholar
  191. 191.
    Acosta J, Chitkara R, Kahn F, Azueta V, et al. Radioactive iodine uptake by a large cell-undifferentiated bronchogenic carcinoma. Clin Nucl Med 1982; 7:368–369.PubMedGoogle Scholar
  192. 192.
    Fernandez-Ulloa M, Maxon HR, Mehta S, Sholiton L. Iodine-131 uptake by primary lung adenocarcinoma, misinterpretation of 131I scan. JAMA 1976; 236:857–858.PubMedGoogle Scholar
  193. 193.
    Langsteger W, Lind P, Koltringer P, Beham A, et al. Misinterpretation of iodine uptake in papillary thyroid carcinoma and primary lung adenocarcinoma. J Cancer Res Clin Oncol 1990; 116:8–12.PubMedGoogle Scholar
  194. 194.
    Misaki T, Takeuchi R, Miyamoto S, Kasagi K, et al. Radioiodine uptake by squamous-cell carcinoma of the lung. J Nucl Med 1994; 35:474–475.PubMedGoogle Scholar
  195. 195.
    Burt RW. Accumulation of 123I in a Warthin’s tumor. Clin Nucl Med 1978; 3:155–156.PubMedGoogle Scholar
  196. 196.
    Harbert JC. Radio iodine therapy of differentiated thyroid carcinoma In Harbert JC, Robertson JS, Held KD, editors. Nuclear Medicine Therapy. New York: Thieme Medical Publishers Inc. 1987:37–89.Google Scholar
  197. 197.
    Wynne HMN, McCartney JC, McClendon JF. Struma ovarii. Am J Obstet Gynecol 1940; 39:263–275.Google Scholar
  198. 198.
    Willemse PHB, Oosterhuis JW, Aalders JG, Piers DA, et al. Malignant struma ovarii treated by ovariectomy, thyroidectomy and I-131 administration. Cancer 1987; 60:178–182.PubMedGoogle Scholar
  199. 199.
    Brenner W, Bohuslavizki KH, Wolf H, Sippel C, et al. Radiotherapy with iodine-131 in recurrent malignant struma ovarii. Eur J Nucl Med 1996; 23:91–94.PubMedGoogle Scholar
  200. 200.
    Lakshmanan M, Reynolds JC, DelVecchio S, Merino MJ, et al. Pelvic radioiodine uptake in a rectal wall teratoma after thyroidectomy for papillary carcinoma. J Nucl Med 1992; 33:1848–1850.PubMedGoogle Scholar
  201. 201.
    Wang PW, Chen HY, Li CH. Uptake of I-131 by an abdominal neurilemoma mimicking metastatic thyroid carcinoma. Clin Nucl Med 1993; 18:964–966.PubMedGoogle Scholar
  202. 202.
    Wilson RL, Cowan RJ. Tc-99m pertechnetate uptake in a thymoma: Case report. Clin Nucl Med 1982; 7:149–150.PubMedGoogle Scholar
  203. 203.
    Bestagno M, Pagliavni R, Maira G. Mediastinal uptake of 131I in patients with thyroid cancer: may it be referred to normal thymus? Eur J Nucl Med 1993; 20(Abstr):648.PubMedGoogle Scholar
  204. 204.
    Goldman M, Bauer SR. A comparative study of iodine uptake by thyroid and thymus glands of male and female Sprague-Dawley rats of different ages. Acta Endocrinol 1977; 85:64–70.PubMedGoogle Scholar
  205. 205.
    Jackson GL, Graham WP III, Flickinger FW, Kennedy TJ. Thymus accumulation of radioactive iodine. Pa Med 1979; 82:37–38.PubMedGoogle Scholar
  206. 206.
    Michigishi T, Mizukami Y, Shuke N, Yokoyama K, et al. Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer. Eur J Nucl Med 1993; 20:75–79.PubMedGoogle Scholar
  207. 207.
    Veronikis IE, Simkin P, Braverman LE. Thymic uptake of iodine-131 in the anterior mediastinum. J Nucl Med 1996; 37:991–992.PubMedGoogle Scholar
  208. 208.
    Vermiglio F, Baudin E, Travagli JP, Caillou B, et al. Iodine concentration by the thymus in thyroid carcinoma. J Nucl Med 1996; 37:1830–1831.PubMedGoogle Scholar
  209. 209.
    Wilson L, Barrington SF, Kettle AG. Physiological uptake occurs in the thymus of young patients treated with radioiodine for thyroid carcinoma. J Nucl Med 1998; 38(Abstr):152P.Google Scholar
  210. 210.
    Wilson LM, Barrington SF, Morrison ID, Kettle, AG, et al. Therapeutic implications of thymic uptake of radioiodine in thyroid carcinoma. Eur J Nucl Med 1998; 25:622–628.PubMedGoogle Scholar
  211. 211.
    Davidson J, McDougall IR. How frequently is the thymus seen on whole-body iodine-131 diagnostic and post-treatment scans. Eur J Nucl Med 2000; 27:425–430.PubMedGoogle Scholar
  212. 212.
    Salvatore M, Saletmich I, Rufini V, Troncone L. Unusual falsepositive radioiodine whole-body scans in patients with differentiated thyroid carcinoma. Clin Nucl Med 1997; 22:380–384.Google Scholar
  213. 213.
    Andreas J, Bruhl K, Eissmer D. False-positive I-131 whole body imaging after I-131 therapy for a follicular carcinoma. Clin Nucl Med 1997; 22:123–124.PubMedGoogle Scholar
  214. 214.
    Shapiro B, Rufini V, Jaruan A, Geatti O, et al. Artifacts, anatomical and physiological variants, and unrelated diseases that might cause falsepositive whole-body 131-I scans in patients with thyroid cancer. Semin Nucl Med 2000; 30:115–132.PubMedGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2006

Authors and Affiliations

  • Brahm Shapiro
    • 1
  • Vittoria Rufini
    • 2
  • Ayman Jarwan
    • 3
  • Onelio Geatti
    • 4
  • Kimberlee J. Kearfott
    • 3
  • Lorraine M. Fig
    • 5
  • Ian D. Kirkwood
    • 6
  • John E. Freitas
    • 7
    • 8
  • Milton D. Gross
    • 9
    • 10
  1. 1.Division of Nuclear Medicine, Department of RadiologyUniversity of Michigan Medical CenterAnn Arbor
  2. 2.Instutito di Medicina NucleareUniversita Cattolica del Sacro CuoreRomeItaly
  3. 3.Department of Nuclear Engineering and Radiological SciencesUniversity of MichiganAnn Arbor
  4. 4.Servizio di Medicina NucleareOspedale MaggioreTriesteItaly
  5. 5.Nuclear Medicine ServiceDepartment of Veterans Affairs Health SystemAnn Arbor
  6. 6.Department of Nuclear MedicineRoyal Adelaide HospitalNorth TerraceAustralia
  7. 7.Nuclear Medicine Services, Department of RadiologySt. Joseph Mercy HospitalAnn Arbor
  8. 8.University of Michigan Medical SchoolAnn Arbor
  9. 9.Division of Nuclear Medicine, Department of RadiologyUniversity of Michigan Medical School
  10. 10.Nuclear Medicine and Radiation Safety ServiceDepartment of Veterans Affairs Health SystemsWashington, DC (field based) and Ann Arbor

Personalised recommendations